1x | | personalized medicine, ABCB1, genetic polymorphisms, adverse events, ABCC2, clinical-pharmacogenetic models, CYP2D6, dopaminergic treatment, genetski polimorfizmi, UGT2B7, lajšanje bolečine, polimorfizem enega nukleotida, imunske kontrolne točke, maligni mezoteliom, alkohol, odvisnost, Parkinson's disease, azbest, sopojavna duševna simptomatika, pharmacogenetics |